Standout Papers

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting 2021 2026 2022 20241.6k
  1. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting (2021)
    Noa Dagan, Noam Barda et al. New England Journal of Medicine
  2. Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting (2021)
    Noam Barda, Noa Dagan et al. New England Journal of Medicine

Immediate Impact

6 by Nobel laureates 19 from Science/Nature 57 standout
Sub-graph 1 of 20

Citing Papers

Persistence in risk and effect of COVID-19 vaccination on long-term health consequences after SARS-CoV-2 infection
2024 Standout
mRNA-based therapeutics: looking beyond COVID-19 vaccines
2024 StandoutNobel

Works of Eldad Kepten being referenced

Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting
2021 Standout
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
2021 Standout

Author Peers

Author Last Decade Papers Cites
Eldad Kepten 796 1732 303 714 18 3.3k
Ben Y. Reis 586 2451 97 1192 68 5.6k
Edward Goldstein 608 1294 78 293 87 4.7k
Chorh Chuan Tan 422 929 64 98 43 3.2k
Suok Kai Chew 434 913 68 159 35 3.1k
Richard Hatchett 415 1110 20 542 44 2.8k
Edith Lau 1073 748 93 61 23 3.8k
Thomas Tsang 127 1712 97 178 55 3.7k
Martin Eichner 416 718 42 162 125 3.7k
Nicolas Voirin 377 398 557 158 97 4.1k
Ruiyun Li 923 1623 57 136 92 4.4k

All Works

Loading papers...

Rankless by CCL
2026